Dear all, As per the attached, we are really pleased to announce up to four positions to join a structural biology team supporting drug discovery in the Northern Institute for Cancer Research and the Chemistry Department, Newcastle University. The structural biology positions, supported by an exciting Alliance Partnership between Newcastle University, CRT, and Astex Pharmaceuticals, will help to complete a highly interdisciplinary team of clinicians, bioscientists, and medicinal and computational chemists working to deliver next generation cancer therapies. We plan to appoint a Senior Research Associate, up to two more junior postdocs, and a technician.
If the possibility appeals, then please hunt out and complete the online application on the Newcastle University website (www.ncl.ac.uk/vacancies<http://www.ncl.ac.uk/vacancies>). [email protected]<mailto:[email protected]> or [email protected]<mailto:[email protected]> With best wishes, Martin Newcastle University has a strong track-record in cancer research and cancer drug discovery, hosting the Cancer Research UK Newcastle Cancer Drug Discovery Programme. The programme has attracted >£17M over the past 5 years in direct funding, and in collaboration with industry partners has generated compounds for clinical trials. Currently, the programme has 5 projects at various stages of small-molecule drug discovery from hit identification to lead optimisation. Astex Pharmaceuticals™ is a dynamic company striving to make an impact in the fight against cancer and other major diseases. The Company has a team of highly qualified and motivated individuals who want to make a difference to patients by playing a key role in the development of novel therapies. Great value is placed on strategic partnerships with leading academic institutes, which is seen as an important means to maximise patient benefit from internationally outstanding science. Newcastle University and Cancer Research Technology have recently established a 5-year research alliance with Astex Pharmaceuticals that will provide significant additional resource for the joint exploitation of innovative targets in cancer. To support the expanded Programme and alliance, Newcastle University is seeking to recruit new staff with expertise in medicinal chemistry, structural biology and drug discovery bioscience. Applicants who have experience in the discovery/development of small molecule anticancer therapeutics or validation of therapeutic targets are invited to apply, although high calibre candidates with expertise in other disease areas are also encouraged. Further details of this exciting opportunity to join a large and successful team of researchers at the cutting edge of cancer drug discovery are available at: www.ncl.ac.uk/vacancies<http://www.ncl.ac.uk/vacancies> The positions can be found under the heading “Search for Job Vacancies” and selecting NICR. The closing date for all positions is the 10th of April. Interviews for the posts will be held during the weeks commencing 22nd and 29th of April. Professor Martin Noble Northern Institute for Cancer Research Paul O'Gorman Building Medical School Newcastle University Framlington Place Newcastle Upon Tyne NE2 4HH E-mail: [email protected]<mailto:[email protected]> Direct line: +44 (0) 191 246 4466
